Product Manager, Single-Cell Sequencing

Job overview

The Product Manager, Single-Cell Sequencing role is office- or home-office-based and ideally located in Seattle, Washington; remote candidates must be willing to travel regularly to Seattle. The stated market pay range is $135,000–$165,000 per year. Parse Biosciences works to accelerate progress in human health and scientific research through single-cell sequencing products. The role owns current and future products in the Evercode product lines and is accountable for their commercial success. It connects customer needs with product development, sales, support, and marketing to guide product positioning, adoption, and launches.

What you'll do

• Manage market development and on-market support for current and future Evercode single-cell products
• define market needs and requirements for new product concepts
• engage customers and assess product strengths and improvement areas
• evaluate market opportunities
• communicate competitive landscape and opportunities
• develop technical sales collateral and presentations
• manage commercial partner relationships
• refine product positioning
• coordinate new product introductions.

What we're looking for

Skills & competencies

product manager

single-cell sequencing

evercode

parse biosciences

seattle wa

remote option

$135k–$165k/year

product launches

market development

customer advocacy

genomics

cross-functional collaboration

Work arrangement

• Weekend coverage required

Benefits & perks

• Medical, dental, vision, and prescription coverage
• 401(k)
• life and disability coverage
• flexible spending accounts
• Seattle transportation program
• 12 paid holidays and winter holiday break
• generous time-off policy.

Why this role

Remote candidates must be able and willing to travel regularly to Seattle headquarters; travel may occur monthly or more often based on business needs.

About the employer

Parse Biosciences is hiring for this role. Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Sector: 54.